Failure of primary atovaquone prophylaxis for prevention of toxoplasmosis in hematopoietic cell transplant recipients.

Gajurel, K; Gomez, C A; Dhakal, R; Vogel, H; Montoya, J G

Gajurel, K; Gomez, C A; Dhakal, R; Vogel, H; Montoya, J G.

Afiliación

Gajurel K; Division of Infectious Diseases and Geographic Medicine, School of Medicine, Stanford University, Stanford, California, USA.
Gomez CA; Division of Infectious Diseases and Geographic Medicine, School of Medicine, Stanford University, Stanford, California, USA.
Dhakal R; Toxoplasma Serology Laboratory, National Reference Center for the Study and Diagnosis of Toxoplasmosis, Palo Alto, California, USA.
Vogel H; Department of Pathology, School of Medicine, Stanford University, Stanford, California, USA.
Montoya JG; Division of Infectious Diseases and Geographic Medicine, School of Medicine, Stanford University, Stanford, California, USA.

Transpl Infect Dis ; 18(3): 446-452, 2016 Jun.

Article en En | MEDLINE | ID: mdl-27016655

Palabras clave

Toxoplasma; atovaquone; hematopoietic cell transplant; preemptive treatment; prophylaxis; toxoplasmosis

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Transpl Infect Dis Asunto de la revista: TRANSPLANTE Año: 2016 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Dinamarca

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google